Optimizing The Channel Strategy To Expand Patient Access To Cell And Gene Therapies

By Melissa Lattanzi

Cell and gene therapies offer groundbreaking potential for patients with rare diseases, but their complex nature necessitates a robust channel strategy for successful delivery. This article explores key considerations for optimizing patient access to these therapies, drawing on insights from Cencora's ThinkLive Cell and Gene Therapy Summit 2024.

The discussion highlights the importance of understanding patient needs, treatment locations, and physician specialties involved. Logistical challenges, including specialized storage, shipping requirements, and high costs, are addressed. Strategies for market planning, site selection, and partnership engagement are also explored. Experts emphasize the need for early engagement with treatment centers, education, and cross-functional collaboration to ensure effective therapy implementation. Real-world examples illustrate the benefits of streamlined workflows, transparent pricing, and proactive communication with stakeholders.

Access the full article to learn how companies can effectively navigate these challenges and bring life-changing therapies to patients in need.